A_DT
germline_NN
TaqI_NN
restriction_NN
fragment_NN
length_NN
polymorphism_NN
in_IN
the_DT
progesterone_NN
receptor_NN
gene_NN
in_IN
ovarian_JJ
carcinoma_NN
-LCB-_-LRB-
see_VB
comments_NNS
-RCB-_-RRB-

Clinical_JJ
outcome_NN
in_IN
ovarian_JJ
carcinoma_NN
is_VBZ
predicted_VBN
by_IN
progesterone_NN
receptor_NN
status_NN
,_,
indicating_VBG
an_DT
endocrine_JJ
aspect_NN
to_TO
this_DT
disease_NN
._.

Peripheral_JJ
leucocyte_NN
genomic_JJ
DNAs_NNS
were_VBD
obtained_VBN
from_IN
41_CD
patients_NNS
with_IN
primary_JJ
ovarian_JJ
carcinoma_NN
and_CC
83_CD
controls_NNS
from_IN
Ireland_NNP
,_,
as_RB
well_RB
as_IN
from_IN
26_CD
primary_JJ
ovarian_JJ
carcinoma_NN
patients_NNS
and_CC
101_CD
controls_NNS
in_IN
Germany_NNP
._.

Southern_NN
analysis_NN
using_VBG
a_DT
human_JJ
progesterone_NN
receptor_NN
-LRB-_-LRB-
hPR_NN
-RRB-_-RRB-
cDNA_NN
probe_NN
identified_VBD
a_DT
germline_NN
TaqI_NN
restriction_NN
fragment_NN
length_NN
polymorphism_NN
-LRB-_-LRB-
RFLP_NN
-RRB-_-RRB-
defined_VBN
by_IN
two_CD
alleles_NNS
:_:
T1_NN
,_,
represented_VBN
by_IN
a_DT
2.7_CD
kb_NN
fragment_NN
;_:
and_CC
T2_NN
,_,
represented_VBN
by_IN
a_DT
1.9_CD
kb_NN
fragment_NN
and_CC
characterised_VBN
by_IN
an_DT
additional_JJ
TaqI_NN
restriction_NN
site_NN
with_IN
respect_NN
to_TO
T1_NN
._.

An_DT
over-representation_NN
of_IN
T2_NN
in_IN
ovarian_JJ
cancer_NN
patients_NNS
compared_VBN
with_IN
controls_NNS
in_IN
the_DT
pooled_JJ
Irish\/German_JJ
population_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.025_CD
-RRB-_-RRB-
was_VBD
observed_VBN
._.

A_DT
difference_NN
-LRB-_-LRB-
P_NN
&lt;_JJR
0.02_CD
-RRB-_-RRB-
in_IN
the_DT
distribution_NN
of_IN
the_DT
RFLP_NN
genotypes_NNS
between_IN
Irish_NNP
and_CC
German_JJ
control_NN
populations_NNS
was_VBD
also_RB
observed_VBN
._.

The_DT
allele_NN
distributions_NNS
could_MD
not_RB
be_VB
shown_VBN
to_TO
differ_VB
significantly_RB
from_IN
Hardy-Weinberg_JJ
distribution_NN
in_IN
any_DT
subgroup_NN
._.

Using_VBG
hPR_NN
cDNA_NN
region-specific_JJ
probes_NNS
,_,
the_DT
extra_JJ
TaqI_NN
restriction_NN
site_NN
was_VBD
mapped_VBN
to_TO
intron_NN
G_NN
of_IN
the_DT
hPR_NN
gene_NN
._.

